Tuesday, February 26, 2013
A research team at The University of Texas M. D. Anderson Cancer Center [1] has developed a new class of tools to fight infectious bacteria that may not respond to traditional antiobiotics.
The team's research focuses on a particular peptide, a short chain of organic molecules, that is effective at penetrating the protective membranes of Gram-negative bacteria that shield them from other medical interventions. These bacteria cause a variety of adverse conditions, such as meningitis and pneumonia, in patients in health-care settings.
Read more about this research in a recent article from the Houston Chronicle [2].